Recently, cell membrane hormonal receptors, such as mPR family (α, β, γ) and progesterone membrane receptor component-1 (PGMRC1), were demonstrated to be functional in breast cancer [32, 33]. This evidence concerns the gene NR4A1 and breast carcinoma.